CNS
Recent breakthroughs in scientific understanding, diagnostic capabilities and delivery machinery have ignited a resurgence of investment and momentum into CNS drug development. However, with high disease heterogeneity, clinical setbacks, and rapidly growing unmet patient needs, addressing some of the most challenging neurodegenerative, neuropsychiatric and neuromuscular disorders requires continued commitment and innovation.
Through our specialised conferences centered on specific indications, modalities or technology niches, we are proud to foster end-to-end insights and connections that accelerate the discovery, clinical development and patient access to a new wave of more transformative CNS treatments.
View and search all of our conferences.
Innovating a New Era of CNS Therapeutics
World CNS Series Sponsorship Prospectus
Following a year of significant pharma acquisitions, first-in-class approvals, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, more companies are prioritizing neuroscience drug development than ever before. Our range of industry-dedicated conferences are designed to cover the full scope of CNS drug development and connect leading minds from CNS-focused pharma and biotech.
Sponsorship Prospectus - Gated Download Form CNS
Testimonials
CNS Conferences – Product Team
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - CNS
"*" indicates required fields